Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind, placebo-controlled, randomised clinical study of Broncho-Vaxom in children with recurrent upper respiratory tract infections
2006-002980-17Phase 4Completed
- Sponsor
- OM Pharma
- Start
- Jun 2007
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in upper respiratory infection (URI) and recurrent upper respiratory tract infection (R-URTI) comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Rate of upper respiratory tract infections during treatment. Started Jun 2007; status: completed.
02
Drugs
OM-85
03
Conditions
upper respiratory infection (URI)recurrent upper respiratory tract infection (R-URTI)
Beyond the preview
Go deeper on 2006-002980-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002980-17.